- Epitomee Medical
Caesarea, Israel (OTE) - Epitomee Medical Ltd. (TASE: EPIT) announces today that the company leadership intends to present Epitomee's Oral Delivery of Biologics Platform at the 14th Annual PODD Conference - Partnership Opportunities...
- 15.10.2024, 13:47:17
- /
- OTE0001
- Epitomee Medical
Caesarea, Israel (OTE) - Epitomee's Ingestible Capsule, Offers a Safe and Effective Prescription Solution for Adults with BMI of 25-40 looking for Alternative Drug Free Solutions for Their Weight Management Needs alongside...
- 16.09.2024, 17:07:47
- /
- OTE0002
- Epitomee Medical
Caesarea, Israel (ots/PRNewswire) - Epitomee® (TASE: EPIT) announced today that on February 27, 2024, it has submitted its Weight Loss Capsule for FDA clearance in the USA, reaching a significant milestone in the...
- 06.03.2024, 15:01:32
- /
- OTE0002
- Epitomee Medical
Caesarea, Israel (ots/PRNewswire) - Epitomee® announces the successful completion of the RESET pivotal clinical trial, for its weight loss capsule. The randomized placebo controlled, double blind trial, investigated...
- 16.01.2024, 14:01:13
- /
- OTE0002